Tumour success for Creo Medical

Aim-listed Creo Medical has won US regulatory approval for an endoscopic tool for cutting out tumours from the gut or bowel without the need for full-blown surgery. The Welsh medical devices company floated in December. Its tools dissect tissue using special microwaves to staunch blood flow.